(Date:11/8/2009)... New book called "Preventing and Healing ...to Giraldo shows that AIDS is a result of multiple...-called immune system stressor agents, which can b...of all, emotional. , Oak...ndash; 8, 2009, cell biologists, physicians, chemi...
(Date:11/8/2009)... Men’s Health Network (MHN) urges milita...ecially those linked to exposure to chemicals, ato.... Bladder cancer is one of those cancers that is t...ose who once smoked or currently smoke cigarettes....November 8, 2009 -- Men’s Health Network (MH...
(Date:11/8/2009)...oes not mean the battle is won," said Dr. Charmain...ewswire/ -- In a vote of 240-194, the Stupak-Ellsw...ent to prohibit abortion mandates and funding in H...United for Life Action President and CEO Dr. Charm... a victory for the pro-life Americans across this ...
(Date:11/8/2009).... 8 Pharmaceutical Rese...ice President Ken Johnson released the following s...ll: ,, "We are disappointed, but not surprised ...s of hardworking Americans as well as nearly half ...s who voted against the bill. ,, "While well in...
(Date:11/8/2009)...ouse Passage of Health Care Reform Bill ,, Cr...ove coverage for all Americans ,, CHICAGO, Nov...tates House of Representatives passed by a vote of...that would strengthen Medicare for seniors and end... millions of Americans out of affordable health co...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3...The Procter & Gamble,Company (NYSE: PG ) ann...61,percent increase for the October - December qua...m the Folgers transaction completed during the,qua...es were three percent below the year-ago quarter a...
...wo-thirds of Americans classified by the governmen...rent economic environment making it even more diff...ed Dr. Olga Stevko, Clinical Hypnotherapist and MD...individual and group sessions. Dr. Olga and her pr...
...nt and Future Growth Opportunities in Transplant D...an Expansion Strategy - , , SAN DIEGO, Calif., Ja... pioneer and leader in nucleic acid diagnostics fo... rapidly growing molecular diagnostics company bas...
...or, rapid transport, and,artificial blood products...,soldiers during the wars in Iraq and Afghanistan....cal transit from battlefield to combat hospitals i...),could be a viable new option for physicians trea...
...ominate State Fiscal Landscape, AHCA/Alliance Urge...deral Medicaid Funds , , WASHINGTON, Jan. 29 W... for vulnerable populations increasing at an alarm...er that will better protect U.S. seniors, ongoing ...
... Varian Medical,Systems (NYSE: VAR ) today repor...56 per diluted share in the first quarter of fisca...erations of $0.46 per diluted share in the year-ag...,continuing operations in the year-ago quarter, fi...
Other Medicine News:Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 2Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 3Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 4Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 5Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 6Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 7Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 8Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 9Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 10Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 11Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 12Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 13Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 14Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 15Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 16Health News:P&G Delivers Second Quarter EPS and Organic Sales in Line with Expectations 17Health News:Expert Hypnotherapist Dr. Olga Stevko Offers Clients Simple and Powerful Tools for Lasting Weight Loss; Dr. Olga Combines Hypnotherapy and NLP to Transform Clients' Limi 2Health News:Expert Hypnotherapist Dr. Olga Stevko Offers Clients Simple and Powerful Tools for Lasting Weight Loss; Dr. Olga Combines Hypnotherapy and NLP to Transform Clients' Limi 3Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 2Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 3Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 4Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 5Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 6Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 7Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 8Health News:Regional Anesthesia Eases Wounded Soldiers' Pain in Iraq and Afghanistan 2Health News:Regional Anesthesia Eases Wounded Soldiers' Pain in Iraq and Afghanistan 3Health News:Stimulus Bill Requires Modification in U.S. Senate to Better Protect Seniors' Ongoing Access to Quality Nursing Home Care 2Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 2Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 3Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 4Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 5Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 6Health News:Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009 7(Date:11/5/2009)...lthea Technologies, Inc., a leading provider of de...ceutical products announced the addition of custom...form of services, which will be overseen by the ne...ulation Development. This investment in an experie..., along with new laboratory facilities and state-o...
(Date:11/5/2009)...FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: "HB...II trial of Topical Interferon Alpha-2b for the tr...atient enrollment, with the required 120th patient...lind and placebo-controlled Phase II trial is unde...atients participating in the trial self-administer...
(Date:11/5/2009)...e/ -- Renee Cobos, MD, a board certified dermatolo... University of California, Irvine, announced today...ults with Thermage CPT®. The updated system, ...ng, features a new vibrating hand piece that incre...rt. ,, "Thermage has always been popular with ...
Breaking Medicine Technology:Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 1Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 3Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 4The San Francisco SPCA Launches Online Guide for Summer Pet Health 26 Safety 53233 1The San Francisco SPCA Launches Online Guide for Summer Pet Health 26 Safety 53233 2The San Francisco SPCA Launches Online Guide for Summer Pet Health 26 Safety 53233 3Governor Eliminates Funding to Domestic Violence Programs 53230 1Governor Eliminates Funding to Domestic Violence Programs 53230 2...rimary Endpoint for Clinical,Trials; Data Presente...ongress -, SOUTH PLAINFIELD, N.J., Sept. 30 PTC ... findings in patients with Duchenne/Becker,Muscula...rld Muscle Society,(WMS) Congress. Results from an...6-minute walk test (6MWT) as a primary outcome mea...
... AMD patients, LOUISVILLE, Ky., Sept. 29 Potenti...company developing medicines for the treatment,of ...oday that the,Company,s leading drug candidate, PO...s Phase I study. POT-4 is a complement inhibitor, ... that could otherwise lead to local,inflammation, ...
Other Medicine Technology:PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 5Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: